```html

Yellow Crusted Scabies (Norwegian Scabies) – A Comprehensive Medical Guide

Overview

Yellow crusted scabies, also known as Norwegian scabies, is a severe, hyper‑infestation form of scabies caused by the microscopic mite Sarcoptes scabiei var. hominis. Unlike classic scabies, which typically produces a few itchy papules, crusted scabies is characterized by thick, warty, yellow‑to‑brown crusts that can cover large areas of the skin. The condition is highly contagious because the patient harbors thousands to millions of mites.

Who it affects: Crusted scabies most often occurs in individuals with weakened immune systems, including:

• Elderly patients, especially those in long‑term care facilities
• People with HIV/AIDS, leukemia, lymphoma, or other hematologic malignancies
• Patients on high‑dose or prolonged systemic corticosteroids, immunosuppressive biologics, or chemotherapy
• Individuals with neurologic disorders that limit scratching (e.g., dementia, Parkinson’s disease)

Prevalence: Classic scabies affects ~200 million people worldwide each year (CDC). Crusted scabies is far rarer, representing <1–2 % of all scabies cases, but outbreaks in nursing homes and psychiatric units are well documented. In a 2018 review of institutional outbreaks, the median attack rate among residents was 19 % (Cleveland Clinic).

Symptoms

Symptoms of crusted scabies develop gradually and may be less pruritic than classic scabies, which can delay diagnosis.

Skin findings

• Thick, hyperkeratotic crusts – yellow, gray, or brown, often resembling psoriasis or eczema.
• Warty papules or plaques – especially on the hands, feet, elbows, knees, scalp, neck, and nail folds.
• Scaling and fissuring – the crusts may crack, leading to painful fissures.
• Burrows – linear tracks may still be visible under the crusts, though they are harder to see.
• Nail changes – onychodystrophy or nail bed hyperkeratosis.

General symptoms

• Itching (pruritus) – often mild or absent, especially in immunocompromised patients.
• Secondary bacterial infection – redness, swelling, warmth, pus, or foul odor.
• Fever and malaise if infection spreads.
• Sleep disturbance due to discomfort.

Causes and Risk Factors

Cause

The disease is caused by infestation with the female Sarcoptes scabiei mite. In crusted scabies, the normal immune response that limits mite numbers fails, allowing an exponential increase in the mite population (up to millions).

Risk factors

• Immunosuppression: HIV with CD4 < 200 cells/µL, organ transplant, chemotherapy.
• Advanced age: Skin barrier thins, and elderly patients often live in close quarters.
• Neurologic impairment: Reduced ability to scratch reduces mechanical removal of mites.
• Chronic skin disease: Psoriasis or eczema can provide a favorable environment.
• Living in institutional settings: Nursing homes, prisons, psychiatric hospitals.
• Previous scabies infestation: Inadequately treated classic scabies can progress.

Diagnosis

Clinical assessment

Diagnosis starts with a thorough history (exposure, immunosuppression) and visual inspection of the characteristic crusted lesions. The presence of a “mite‑burrow” pattern under the crusts, especially on the finger webs, wrists, and elbows, supports the diagnosis.

Laboratory and skin‑scraping tests

• Skin scraping – A sterile blade is used to remove material from the crust. The sample is placed on a slide with mineral oil and examined under a microscope for mites, eggs, or fecal pellets. In crusted scabies, a high density of mites is typically seen.
• Dermatoscopy (mite‑finder) – A handheld dermatoscope can reveal “delta wing” or “jet‑liner” signs of the mite.
• Skin biopsy – Rarely needed, but histology shows hyperkeratosis, spongiosis, and mites within the stratum corneum.

Additional tests

If secondary bacterial infection is suspected, a wound culture may be ordered. Blood tests (CBC, CRP) help gauge systemic inflammation.

Treatment Options

Topical scabicides

• Permethrin 5 % cream – Applied to the entire body from the neck down (and scalp in infants) and left for 8–14 hours before washing. For crusted scabies, daily application for 5–7 days is recommended.
• Benzyl benzoate 10–25 % – An oil‑based lotion applied nightly for 3–5 nights; can be irritating.
• Crotamiton 10 % (Eurax) – Less effective, but useful for patients intolerant to permethrin.

Systemic therapy

• Ivermectin (Oral) – 200 µg/kg as a single dose, repeated after 1‑2 days, then weekly for 2–4 weeks. In severe crusted disease, a regimen of 5‑7 doses over 2‑3 weeks is common.
• Combination therapy – Guidelines (CDC, WHO) recommend a combination of oral ivermectin plus topical permethrin for the most rapid clearance.

Adjunctive measures

• Antibiotics – If secondary bacterial infection is present (e.g., cellulitis, impetigo), prescribe appropriate agents such as cephalexin or clindamycin.
• Keratolytic agents – Salicylic acid 5 % or urea 10‑20 % creams can soften crusts before scabicide application.
• Bathing and debridement – Warm water baths with gentle scrubbers can remove superficial crusts, improving drug penetration.

Environmental control

All clothing, bedding, and towels used by the patient in the preceding 72 hours must be washed at ≥60 °C (140 °F) or sealed in plastic bags for 2 weeks. Non‑washable items should be isolated or discarded.

Living with Yellow Crusted Scabies (Norwegian Scabies)

Even after successful treatment, patients may need ongoing care to prevent recurrence and manage skin integrity.

• Skin hygiene – Daily gentle cleansing with fragrance‑free soap; avoid harsh scrubs.
• Moisturize – Apply emollient creams (e.g., petroleum jelly, ceramide‑rich lotions) after bathing to keep the stratum corneum supple.
• Regular follow‑up – Schedule visits with a dermatologist or primary care provider 2–4 weeks post‑treatment to confirm eradication.
• Monitor for secondary infection – Look for increasing redness, swelling, warmth, or drainage; treat promptly.
• Manage comorbidities – Optimize control of HIV, diabetes, or other immunosuppressive conditions.
• Assistive devices – Use soft gloves or foot covers to protect fragile skin while applying medication.

Prevention

• Prompt treatment of classic scabies – Early therapy prevents progression to crusted disease.
• Isolation of affected individuals – In communal settings, place patients in a private room until they have completed at least the first dose of ivermectin and 24 hours of topical treatment.
• Environmental cleaning – Wash linens, clothing, and upholstery as described above.
• Hand hygiene – Wash hands with soap and water or alcohol‑based sanitizer after touching potentially contaminated surfaces.
• Education of caregivers – Training on proper application of scabicides, use of gloves, and disposal of contaminated materials.
• Vaccination & prophylaxis – No vaccine exists, but prophylactic ivermectin (single dose) is recommended for close contacts in outbreak settings (CDC).

Complications

If left untreated, crusted scabies can lead to serious health issues:

• Secondary bacterial infection – Streptococcus pyogenes or Staphylococcus aureus can cause cellulitis, impetigo, or even sepsis.
• Post‑streptococcal glomerulonephritis – Resulting from untreated skin infection.
• Erythroderma – Widespread skin inflammation that can impair thermoregulation.
• Chronic skin breakdown – Painful fissures increase risk of ulceration.
• Outbreaks – Highly contagious mites can rapidly spread in care facilities, affecting dozens of residents.
• Psychosocial impact – Stigma, isolation, and depression are common in chronic dermatologic disease.

When to Seek Emergency Care

---

Sources: CDC – Scabies; Mayo Clinic; Cleveland Clinic; WHO Fact Sheet; NIH – Crusted Scabies Review (2020).

```